Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/204998 |
Resumo: | Chronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression. |
id |
USP-31_537ff778f7d8bef75f45855bc2e5aae0 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/204998 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic LeukemiaChronic lymphocytic leukemia PrognosisMicroparticlesThrombin GenerationChronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-12-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20499810.1590/s2175-97902022e19407 Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204998/194506Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGontijo Evangelista, Fernanda Cristina Ferrão, Aline Lúcia MenezesDuarte, Rita Carolina FigueiredoGomes, Lorena CaixetaAlves, Luan Carlos Vieira Nunes, Fernanda FreireBraga, Tatiane VieiraSantiago, Marie Gabriele Silva Araújo, Sergio Schusterschitz daCarvalho, Maria das GraçasSabino, Adriano2023-05-26T13:23:18Zoai:revistas.usp.br:article/204998Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-26T13:23:18Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
title |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
spellingShingle |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia Gontijo Evangelista, Fernanda Cristina Chronic lymphocytic leukemia Prognosis Microparticles Thrombin Generation |
title_short |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
title_full |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
title_fullStr |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
title_full_unstemmed |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
title_sort |
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia |
author |
Gontijo Evangelista, Fernanda Cristina |
author_facet |
Gontijo Evangelista, Fernanda Cristina Ferrão, Aline Lúcia Menezes Duarte, Rita Carolina Figueiredo Gomes, Lorena Caixeta Alves, Luan Carlos Vieira Nunes, Fernanda Freire Braga, Tatiane Vieira Santiago, Marie Gabriele Silva Araújo, Sergio Schusterschitz da Carvalho, Maria das Graças Sabino, Adriano |
author_role |
author |
author2 |
Ferrão, Aline Lúcia Menezes Duarte, Rita Carolina Figueiredo Gomes, Lorena Caixeta Alves, Luan Carlos Vieira Nunes, Fernanda Freire Braga, Tatiane Vieira Santiago, Marie Gabriele Silva Araújo, Sergio Schusterschitz da Carvalho, Maria das Graças Sabino, Adriano |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Gontijo Evangelista, Fernanda Cristina Ferrão, Aline Lúcia Menezes Duarte, Rita Carolina Figueiredo Gomes, Lorena Caixeta Alves, Luan Carlos Vieira Nunes, Fernanda Freire Braga, Tatiane Vieira Santiago, Marie Gabriele Silva Araújo, Sergio Schusterschitz da Carvalho, Maria das Graças Sabino, Adriano |
dc.subject.por.fl_str_mv |
Chronic lymphocytic leukemia Prognosis Microparticles Thrombin Generation |
topic |
Chronic lymphocytic leukemia Prognosis Microparticles Thrombin Generation |
description |
Chronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-19 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204998 10.1590/s2175-97902022e19407 |
url |
https://www.revistas.usp.br/bjps/article/view/204998 |
identifier_str_mv |
10.1590/s2175-97902022e19407 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204998/194506 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1819596930647326720 |